Latest revenue
$1.88B
as of 2026-03-31
Latest net income
—
as of 2026-03-31
Net margin
—
as of 2026-03-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $19.41B
- Enterprise value
- $20.44B
- P/E (trailing)
- 4.8×
- Forward P/E
- —
- P/B
- 0.73×
- Dividend yield
- 3.8%
- 52-wk high
- $329.16
- 52-wk low
- $257.17
- Beta
- —
- Shares out
- 66.6M
5-year trend
What this company does
CME Group operates the world's largest derivatives marketplace, running futures and options exchanges (CME, CBOT, NYMEX, COMEX) where traders hedge and speculate on interest rates, equities, energy, metals, and agricultural commodities. Clearing and transaction fees drive the business, generating $1.54 billion of $1.88 billion in quarterly revenue, supplemented by market data subscriptions. Trading volumes surged in early 2026, lifting revenue 14% year-over-year, while the company converted its Series G preferred stock to common and returned $3.2 billion to shareholders via dividends and buybacks.
Generated from CME's filing dated 2026-02-26
Key risks
- Clearing house concentration: $165B in performance bonds/guaranty fund contributions create systemic counterparty exposure if a major clearing member defaults.
- Capital return outpacing earnings: $2.7B dividends plus $539M buybacks in Q1 drove equity down $2.1B despite $1.15B net income.
- Revenue cyclicality: 15% Q1 revenue growth tied to volatile trading volumes; investment income ($1.39B) depends on rate environment and member float.
Generated from CME's filing dated 2026-02-26
Profitability
Operating margin
64.9%
1.1%Net margin
62.5%
8.6%Return on equity
14.2%
6.5%Return on assets
2.1%
20.0%Leverage
Debt / equity
5.91×
41.0%Long-term debt / equity
0.12×
17.8%Debt / assets
85.5%
5.9%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $1.88B | +14.5% | — | — | — |
Q4 2025 2025-12-31 | $1.65B | +8.1% | — | — | — |
Q3 2025 2025-09-30 | $1.54B | -3.0% | — | — | — |
Q2 2025 2025-06-30 | $1.69B | +10.4% | — | — | — |
Q1 2025 2025-03-31 | $1.64B | +10.4% | — | — | — |
Q4 2024 2024-12-31 | $1.53B | — | — | — | — |
Q3 2024 2024-09-30 | $1.58B | +18.4% | — | — | — |
Q2 2024 2024-06-30 | $1.53B | +12.7% | — | — | — |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Security & Commodity Brokers, Dealers, Exchanges & Services · SIC 6200
Your notes
Keep private notes on CME — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$655.1K
Insider selling
$30.5M
Net activity
−$29.9M
Distinct insiders
14
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns CME
No institutional holdings on file for CME yet.
Source: SEC Form 13F-HR. Updated quarterly (45-day filing lag).
Top questions investors are asking
- 1
Investment income jumped to $1.39B against $1.25B in offsetting non-operating expense—what's the true economic spread, and how sensitive is it to rate cuts?
- 2
Clearing and transaction fees grew 15% YoY to $1.54B; how much was volume versus rate per contract, and is pricing sustainable amid FMX competition?
- 3
With $2.7B in dividends versus $1.26B operating cash flow this quarter, how are you funding the gap without pressuring the AA credit rating?
Refreshed when CME files a new report · last from 2026-02-26